Showing results (51-60 of 1,644) with videos related to
Sort By:
Pageof 165
Therapeutic Innovation & Regulatory Science|September 9, 2022
Pediatric Clinical Research Networks: Role in Accelerating Development of Therapeutics in ChildrenRachel G Greenberg, Susan McCune, Sabah Attar, et al.Therapeutic Innovation & Regulatory Science|October 22, 2022
Regulatory Reform Outcomes and Accelerated Regulatory Pathways for New Prescription Medicines in AustraliaAlina Yoffe, Johnson Liu, Greg Smith, et al.Therapeutic Innovation & Regulatory Science|September 3, 2022
The Relative Contributions of NIH and Private Sector Funding to the Approval of New BiopharmaceuticalsDuane Schulthess, Harry P Bowen, Robert Popovian, et al.Therapeutic Innovation & Regulatory Science|March 30, 2019
Interdisciplinary Safety Evaluation and Quantitative Safety Monitoring: Introduction to a Series of PapersJonathan H Seltzer, Judy Li, William WangTherapeutic Innovation & Regulatory Science|March 8, 2021
A Survey of Survival Outcomes for Targeted Cancer Drugs Approved by the US Food and Drug AdministrationQian He, Qiu Li, Fanzhen Lv, et al.Therapeutic Innovation & Regulatory Science|October 27, 2018
Abbreviated New Drug Applications: Generic Drug User Fee Amendments Act Analysis of Application Quality MetricsJason Woo, Jingyu Julia Luan, Zili Li, et al.Therapeutic Innovation & Regulatory Science|October 31, 2018
Survey of Awareness and Perceptions of Canadians on the Benefits and Risks of Clinical TrialsDonald J Willison, Dawn P Richards, Alison Orth, et al.Therapeutic Innovation & Regulatory Science|November 2, 2018
Comparisons of Usual Dose of Pharmaceutical Products Used in Japan and United States: Can Differences Be Explained by Pharmacokinetics Alone?Risa Takayanagi, Yuuki Endo, Koji Kimura, et al.Therapeutic Innovation & Regulatory Science|November 10, 2018
How Did These Data Get Here? Recommendations for the Analysis of Data From ClinicalTrials.govTodd A DurhamTherapeutic Innovation & Regulatory Science|November 2, 2022
Trends and Characteristics of New Drug Approvals in China, 2011-2021Ling Su, Sen Liu, Guanqiao Li, et al.Pageof 165